AIGH Capital Management's acquisition of a 9.4% stake in IN8bio is a substantial investment, suggesting they see long-term value in the company. This could lead to increased investor interest and a positive short-term impact on IN8bio's stock price, as the market often views such investments by institutional investors as a positive signal.